Activation of NF‐κB is involved in CCL18/MTDH‐induced EMT, which intrinsically enhances the ability of cell migration and invasion, suggesting that MTDH may be used as a therapeutic target for the inhibition of SCCHN metastasis. This evidence concerns the gene MTDH and head and neck squamous cell carcinoma.